Home          View all 329 MoA classes  

      

Enter a class name or drug name above to search the database.

Mitogen-Activated Protein Kinase Kinase 2 Inhibitors [MoA] Mechanism of Action Drugs

NDC Number Brand Name Generic Name Labeler Dosage Form DEA Schedule Marketing Start Date
0310-0610 KOSELUGO SELUMETINIB AstraZeneca Pharmaceuticals LP CAPSULE 2020-04-16
0310-0625 KOSELUGO SELUMETINIB AstraZeneca Pharmaceuticals LP CAPSULE 2020-04-16
0310-0635 KOSELUGO SELUMETINIB AstraZeneca Pharmaceuticals LP GRANULE 2025-09-10
0310-0640 KOSELUGO SELUMETINIB AstraZeneca Pharmaceuticals LP GRANULE 2025-09-10
82448-130 Gomekli mirdametinib SpringWorks Therapeutics, Inc. CAPSULE 2025-02-11
82448-134 Gomekli mirdametinib SpringWorks Therapeutics, Inc. TABLET, FOR SUSPENSION 2025-02-11
82448-260 Gomekli mirdametinib SpringWorks Therapeutics, Inc. CAPSULE 2025-02-11

 Mechanism of Action Classification 

Loading full table content...